AU2002217970A1 - Wnt signalling assay, methods and uses thereof - Google Patents

Wnt signalling assay, methods and uses thereof

Info

Publication number
AU2002217970A1
AU2002217970A1 AU2002217970A AU1797002A AU2002217970A1 AU 2002217970 A1 AU2002217970 A1 AU 2002217970A1 AU 2002217970 A AU2002217970 A AU 2002217970A AU 1797002 A AU1797002 A AU 1797002A AU 2002217970 A1 AU2002217970 A1 AU 2002217970A1
Authority
AU
Australia
Prior art keywords
methods
wnt signalling
signalling assay
assay
wnt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002217970A
Inventor
David Bumcrot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Curis Inc
Original Assignee
Curis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curis Inc filed Critical Curis Inc
Publication of AU2002217970A1 publication Critical patent/AU2002217970A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2002217970A 2000-11-28 2001-11-28 Wnt signalling assay, methods and uses thereof Abandoned AU2002217970A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25368700P 2000-11-28 2000-11-28
US60/253,687 2000-11-28
US26457901P 2001-01-26 2001-01-26
US60/264,579 2001-01-26
PCT/US2001/044862 WO2002044378A2 (en) 2000-11-28 2001-11-28 Wnt signalling assay, methods and uses thereof

Publications (1)

Publication Number Publication Date
AU2002217970A1 true AU2002217970A1 (en) 2002-06-11

Family

ID=26943481

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217970A Abandoned AU2002217970A1 (en) 2000-11-28 2001-11-28 Wnt signalling assay, methods and uses thereof

Country Status (2)

Country Link
AU (1) AU2002217970A1 (en)
WO (1) WO2002044378A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002244757A1 (en) * 2001-04-02 2002-10-15 Bayer Aktiengesellschaft Method for specifically detecting, isolating and characterizing cells from body samples by transfecting nucleic acid constructs
US7682607B2 (en) 2001-05-01 2010-03-23 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
US7713526B2 (en) 2001-05-01 2010-05-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
WO2006044402A1 (en) * 2004-10-14 2006-04-27 Compass Pharmaceuticals Llc Furazano `3, 4-b ! pyrazynes and their use as anti-tumor agents
ES2353401T3 (en) * 2005-06-29 2011-03-01 Schering Corporation OXIDIAZOLOPIRAZINAS AND TIADIAZOLOPIRAZINAS 5,6-DI-REPLACED AS LIGANDOS OF THE CXC-CHEMIOCINE RECEIVER.
WO2009137630A1 (en) * 2008-05-07 2009-11-12 Wintherix Llc Methods for identifying compounds that modulate wnt signaling in cancer cells
AU2009260503B2 (en) 2008-05-27 2014-03-27 The Board Of Regents Of The University Of Texas System Wnt protein signalling inhibitors
WO2011038049A1 (en) 2009-09-22 2011-03-31 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
WO2013009259A1 (en) * 2011-07-14 2013-01-17 Biochromix Pharma Ab Novel compounds and their use in therapy
WO2014161046A1 (en) * 2013-04-04 2014-10-09 The Walter And Eliza Hall Institute Of Medical Research Methods of treating diseases characterized by excessive wnt signalling
WO2017151063A1 (en) * 2016-03-03 2017-09-08 Agency For Science, Technology And Research Use of furazano[3,4-b]pyrazine derivatives for chemotherapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851775A (en) * 1997-03-20 1998-12-22 Johns Hopkins University β-catenin, Tcf-4, and APC interact to prevent cancer

Also Published As

Publication number Publication date
WO2002044378A2 (en) 2002-06-06
WO2002044378A3 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
AU2001277245A1 (en) Microarrays of functional biomolecules, and uses therefor
AU2001271744A1 (en) Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9
AU2001244579A1 (en) Block copolymer
EP1247815A3 (en) Modified oligonucleotides and uses thereof
AU2001290228A1 (en) Block copolymer
AU2001286051A1 (en) Microfluidic
AUPR216100A0 (en) Porous polymers
AU2002359392A1 (en) Rapid prion-detection assay
AU2001235773A1 (en) Electro-luminiscent polymers, their preparation and uses
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU2001254959A1 (en) Test signalling
AU2002314181A1 (en) Novel endothelially expressed dnas and proteins, and their use
AU2001285810A1 (en) High functional polymers
AU2002217970A1 (en) Wnt signalling assay, methods and uses thereof
AU2001244687A1 (en) Micro-array
AU6594401A (en) 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
AU2002245107A1 (en) Improved biochip
AU2002212445A1 (en) Signalling means
GB0007933D0 (en) Assays,methods and means
AU2001232041A1 (en) Improved assay
AU2001232132A1 (en) Novel assay
AU2001266689A1 (en) 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof
AU4670901A (en) Homocysteine assay
AU2001240793A1 (en) Novel assay
AU3440700A (en) Assays, methods and means